alexa Contact Editorial in Chief - Clinical Pharmacology and Biopharmaceutics Journal
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Shufeng Zhou
Shufeng Zhou
Department of Pharmaceutical Sciences
University of South Florida

Dr. Zhou is presently a Professor, Associate Dean of International Research, and Chair of the Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, Florida. Professor Zhou completed his clinical training in China in 1989 and obtained his PhD in 2001 from the School of Medicine, the University of Auckland, New Zealand. Professor Zhou has published more than 330 peer-reviewed papers in various pharmacology and medical journals including New England Journal of Medicine, Cancer Research, Journal of Biological Chemistry, Clinical Pharmacology and Therapeutics, and Clinical Cancer Research. He has also published 16 books and book chapters and more than 200 conference abstracts. His work has been cited more than 4,500 times by other colleagues. He is involved in the development of more than 10 lead compounds. To date, he has trained 24 PhD students, 12 MSc/Honors students, and 14 postdoctoral staff. Dr. Zhou serves as an editor-in-chief or editor for Drug, Healthcare and Patient Safety, Drug Metabolism Letters, and Current Drug Metabolism and is the editorial board member of other 20 medical and pharmacological journals. Dr. Zhou has given more than 80 invited seminars/keynote presentations to a variety of academic institutes, government agencies, and high-profile international conferences.

Research Interest

Drug discovery, Drug metabolism, Drug transport, Pharmacogenomics, Nanomedicine, Herbal medicines, and Stem cells